Kristine Kearns
Papers
1
Total Citations
4
H-Index
1
About
Dr. Kristine Kearns is a leading figure in virology and vaccine development, with a specialized focus on combating dengue fever, a disease threatening half the global population. Her most prominent contribution is the development of a fully automated high-throughput immuno-µPlaque assay, a groundbreaking tool for live-attenuated tetravalent dengue vaccine development. This innovation, detailed in her 2024 highly cited work, streamlines the critical process of quantifying and characterizing live virus vaccines, accelerating the path toward an effective tetravalent formulation. By replacing manual, labor-intensive methods with an automated, high-throughput system, Dr. Kearns’s work directly addresses a major bottleneck in vaccine manufacturing and quality control. Her research is pivotal for ensuring the potency and consistency of leading vaccine candidates, offering a scalable solution to a global health crisis. With her work already garnering significant attention and citations, Dr. Kearns is establishing herself as a key innovator in translational virology, providing essential tools that bring the world closer to preventing the debilitating impact of dengue disease.
Research Focus
Key Achievements
Top Papers
- 1